Homeopathic medicines for wisdom teeth

Efficacy of Cheiranthus cheiri 30CH in treatment of pericoronitis: A double-blind, randomized, placebo-controlled pilot trial by using pain visual analogue scale

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051254

Enrollment

Registered

2023-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K011- Impacted teeth

Interventions

Intervention1: Cheiranthus cheiri 30CH, 4 doses a day for 3 days with concomitant care: Intervention is planned as administering Cheiranthus cheiri 30CH, 4 doses a day for 3 days. Each dose will consi

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 16 and 40 years. 2. Participants of either sex. 3. Patients having no history of tooth extraction/ exfoliation. 4. No filling for wisdom teeth or the second molar been undertaken before the study. 5. Providing with written informed consent voluntarily to participate in the study

Exclusion criteria

Exclusion criteria: 1. Incomplete root formation of the third molar 2. Craniofacial anomalies such as achondroplasia, progeria, oxycephaly, cleidocranial dysostosis 3. Down syndrome 4. Previous trauma or pathology 5. Pregnancy, puerperium, lactation 6. Vulnerable population – unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people 7. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 8. Self-reported immune-compromised state 9. Substance abuse and/or dependence 10. Already undergoing homeopathic treatment for chronic disease within last 3 months 11. Simultaneous participation in any other clinical trial

Design outcomes

Primary

Measure	Time frame
Pain intensity measuring 0-100 mm visual analogue scaleTimepoint: Day 0, 3, 5, 7, 10, and 14	—

Secondary

Measure	Time frame
Blood ESR, CRP, and TLCTimepoint: Baseline and after 14 days;Oral Health Impact Profile 14 (OHIP-14) questionnaireTimepoint: Baseline and after 14 days;Swelling and trismusTimepoint: Day 0, 3, 5, 7, 10, and 14	—

Countries

India

Contacts

Public ContactAritra Roy Chowdhury

D. N. De Homoeopathic Medical College and Hospital

chandra.suman188@gmail.com9871630660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026